Healthcare provider profile · identity verified

Peter Bendt, MD

Family Practice · FRANKLIN, PA · NPI 1326010588

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	809	232
Lisinopril	Lisinopril	796	216
Atorvastatin Calcium	Atorvastatin Calcium	734	188
Levothyroxine Sodium	Levothyroxine Sodium	491	122
Omeprazole	Omeprazole	371	79
Losartan Potassium	Losartan Potassium	336	81
Metformin Hcl	Metformin Hcl	321	85
Metoprolol Tartrate	Metoprolol Tartrate	313	78
Ezetimibe	Ezetimibe	302	103
Amlodipine Besylate	Amlodipine Besylate	269	70
Pantoprazole Sodium	Pantoprazole Sodium	262	65
Gabapentin	Gabapentin	238	56
Simvastatin	Simvastatin	216	55
Eliquis	Apixaban	205	41
Metoprolol Succinate	Metoprolol Succinate	157	42
Furosemide	Furosemide	155	41
Allopurinol	Allopurinol	143	32
Clopidogrel	Clopidogrel Bisulfate	141	31
Sertraline Hcl	Sertraline Hcl	133	33
Tamsulosin Hcl	Tamsulosin Hcl	132	39
Albuterol Sulfate Hfa	Albuterol Sulfate	120	49
Hydrochlorothiazide	Hydrochlorothiazide	118	33
Ozempic	Semaglutide	117	19
Potassium Chloride	Potassium Chloride	114	30
Atenolol	Atenolol	104	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	96	24
Terazosin Hcl	Terazosin Hcl	95	17
Alendronate Sodium	Alendronate Sodium	93	25
Montelukast Sodium	Montelukast Sodium	91	22
Breo Ellipta	Fluticasone/Vilanterol	86	16
Metformin Hcl Er	Metformin Hcl	81	25
Chlorthalidone	Chlorthalidone	76	23
Citalopram Hbr	Citalopram Hydrobromide	76	23
Xarelto	Rivaroxaban	75	15
Meloxicam	Meloxicam	72	18
Carvedilol	Carvedilol	71	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	69	17
Spironolactone	Spironolactone	63	16
Duloxetine Hcl	Duloxetine Hcl	62	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	22
Tramadol Hcl	Tramadol Hcl	59	21
Famotidine	Famotidine	58	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	56	18
Lorazepam	Lorazepam	56	16
Glipizide	Glipizide	55	13
Trazodone Hcl	Trazodone Hcl	55	16
Glipizide Er	Glipizide	52	16
Hydralazine Hcl	Hydralazine Hcl	50	12
Trulicity	Dulaglutide	50	11
Jardiance	Empagliflozin	49	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	13
Mupirocin	Mupirocin	48	35
Paroxetine Hcl	Paroxetine Hcl	48	11
Farxiga	Dapagliflozin Propanediol	47	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	11
Clonazepam	Clonazepam	46	suppressed
Fluticasone Propionate	Fluticasone Propionate	44	19
Levetiracetam	Levetiracetam	43	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	43	suppressed
Prednisone	Prednisone	42	18
Buspirone Hcl	Buspirone Hcl	41	12
Enalapril Maleate	Enalapril Maleate	41	suppressed
Valsartan	Valsartan	41	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	39	17
Propranolol Hcl	Propranolol Hcl	39	12
Celecoxib	Celecoxib	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Topiramate	Topiramate	35	suppressed
Finasteride	Finasteride	34	suppressed
Labetalol Hcl	Labetalol Hcl	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Irbesartan	Irbesartan	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	24
Naproxen	Naproxen	30	11
Baclofen	Baclofen	29	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Diltiazem Hcl	Diltiazem Hcl	27	suppressed
Humalog Kwikpen U-100	Insulin Lispro	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Cholestyramine	Cholestyramine (With Sugar)	26	suppressed
Gemfibrozil	Gemfibrozil	26	suppressed
Risperidone	Risperidone	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Prazosin Hcl	Prazosin Hcl	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Glimepiride	Glimepiride	22	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	19
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Mometasone Furoate	Mometasone Furoate	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Nabumetone	Nabumetone	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Carbamazepine	Carbamazepine	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	11
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	13
Divalproex Sodium	Divalproex Sodium	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Cephalexin	Cephalexin	13	12
Ketoconazole	Ketoconazole	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Dofetilide	Dofetilide	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Minoxidil	Minoxidil	12	suppressed
Modafinil	Modafinil	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error